RxDoctor Payments Data

Triffany Farrell

Family · Fredericksburg, VANPI 1902667066

Payments from drug & device makers

$1,627in general payments, 2019–2025

Across 60 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$325
  • Philips North America LLC$294
  • Novo Nordisk$197
  • Abiomed$155
  • Boston Scientific$121
  • Edwards Lifesciences$96
  • plus $440 from 19 others

What the payments were for

  • Food & beverage$1,627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,627 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$56,650
Rosuvastatin Calcium66$1,034
Ezetimibe28$858
Metoprolol Succinate67$803
Bumetanide16$555
Atorvastatin Calcium65$529
Carvedilol58$487
ClopidogrelClopidogrel Bisulfate41$316
Losartan Potassium35$293
Spironolactone32$234
Furosemide53$212
Metoprolol Tartrate26$122
Lisinopril32$109
Amlodipine Besylate37$73

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$56,65046 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,332 family providers in Virginia.

Other family in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →